Samir Rashmikant Patel - Jun 30, 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role: Director
Signature: /s/ Wendy F. DiCicco, as Attorney-in-Fact for Samir Patel
Stock symbol: AKTX
Transactions as of: Jun 30, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/2/2024, 04:30 PM
Previous filing: Jun 4, 2024
Next filing: Oct 2, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKTX	Ordinary Shares, par value $0.0001 per share	Award	$0	+91.4M		$0.00	91.4M	Jun 30, 2024	Direct	F1, F2
holding	AKTX	Ordinary Shares, par value $0.0001 per share						3.41B	Jun 30, 2024	PranaBio Investments LLC	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2	These shares represent restricted stock units ("RSUs") granted under the Issuer's 2023 Equity Incentive Plan, with each such RSU representing the right to receive one ordinary share, par value $0.0001. One-hundered percent (100%) of the RSUs vested on the date of grant, or June 30, 2024.

Remarks:

See Exhibit 24.1 - Power of Attorney